Lonza Group AG现在的股价报67.65 Lonza Group AG的股票在哪间交易所挂牌交易？ Lonza Group AG的股票在OTC市场挂牌交易。 Lonza Group AG的股票代码是什么？ Lonza Group AG的股票代码是“LZAGY。” Lonza Group AG有分红吗？当前的股息收益率是多少？ Lonza Group AG的股息收益率是0.19% ...

01.04.2025 / 07:00 CET/CEST Basel, Switzerland, 1 April 2025 – Lonza today announced the successful completion of its share buyback program of up to CHF 2 billion which was launched on 3 April 2023.

How Lonza Capsules & Health Ingredients (CHI) is redefining drug delivery with cutting-edge capsule innovation, customer-first service, and a strong commitment to sustainability Frank Romanski, Ph.D., ...

Basel-based Lonza joined CMAC, a center for medicines manufacturing research, to enhance its service offering for particle technologies and drug product development and manufacture. Based at the ...

Lonza, a global development and manufacturing partner to the pharmaceutical and biotech markets, has joined CMAC, a center for medicines manufacturing research, to enhance its service offering for ...

Lonza Group Ag (LZAGY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

What’s going on here? Lonza Group has eased investor concerns by confirming that its exposure to US tariffs is limited, calming fears about potential levies affecting its operations and financial ...

Ethris has partnered with contract development and manufacturing organisation Lonza for the development of room-temperature stable mRNA vaccine candidates targeting respiratory conditions.

Credit: mi_viri/Shutterstock. Ethris has partnered with contract development and manufacturing organisation Lonza for the development of room-temperature stable mRNA vaccine candidates targeting ...